Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Cancers × ADI PEG20 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 3 Melanoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Hepatocellular 2 Sarcoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Ichthyosis, X-Linked 1 HER2 Negative Metastatic Breast Cancer 1 Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Cancers 1 Advanced Pancreatic Cancer 1

Interventions

pembrolizumab 1 Sirolimus 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1 Albumin-Bound Paclitaxel 1 ADI PEG20 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03254732 2022-04-27

Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

Polaris Group

Phase 1 Terminated

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡